These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9022023)

  • 1. Major histocompatibility complex recognition by immune receptors: differences among T cell receptor versus antibody interactions with the VSV8/H-2Kb complex.
    Witte T; Smolyar A; Spoerl R; Goyarts EC; Nathenson SG; Reinherz EL; Chang HC
    Eur J Immunol; 1997 Jan; 27(1):227-33. PubMed ID: 9022023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topology of T cell receptor-peptide/class I MHC interaction defined by charge reversal complementation and functional analysis.
    Chang HC; Smolyar A; Spoerl R; Witte T; Yao Y; Goyarts EC; Nathenson SG; Reinherz EL
    J Mol Biol; 1997 Aug; 271(2):278-93. PubMed ID: 9268659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Point mutations in the beta chain CDR3 can alter the T cell receptor recognition pattern on an MHC class I/peptide complex over a broad interface area.
    Goyarts EC; Vegh Z; Kalergis AM; Hörig H; Papadopoulos NJ; Young AC; Thomson CT; Chang HC; Joyce S; Nathenson SG
    Mol Immunol; 1998 Jul; 35(10):593-607. PubMed ID: 9823758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A molecular basis for how a single TCR interfaces multiple ligands.
    Boesteanu A; Brehm M; Mylin LM; Christianson GJ; Tevethia SS; Roopenian DC; Joyce S
    J Immunol; 1998 Nov; 161(9):4719-27. PubMed ID: 9794402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognition of an MHC class I-restricted antigenic peptide can be modulated by para-substitution of its buried tyrosine residues in a TCR-specific manner.
    Saito NG; Chang HC; Paterson Y
    J Immunol; 1999 May; 162(10):5998-6008. PubMed ID: 10229839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. V beta 5+ T cell receptors skew toward OVA+H-2Kb recognition.
    Dillon SR; Jameson SC; Fink PJ
    J Immunol; 1994 Feb; 152(4):1790-801. PubMed ID: 8120388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4 and CD8 accessory molecules function through interactions with major histocompatibility complex molecules which are not directly associated with the T cell receptor-antigen complex.
    Lustgarten J; Waks T; Eshhar Z
    Eur J Immunol; 1991 Oct; 21(10):2507-15. PubMed ID: 1915555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mode of ligand recognition by two peptide:MHC class I-specific monoclonal antibodies.
    Messaoudi I; LeMaoult J; Nikolić-Zugić J
    J Immunol; 1999 Sep; 163(6):3286-94. PubMed ID: 10477598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TcR recognition of the MHC-peptide dimer: structural properties of a ternary complex.
    Vasmatzis G; Cornette J; Sezerman U; DeLisi C
    J Mol Biol; 1996 Aug; 261(1):72-89. PubMed ID: 8760503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Participation of L3T4 in T cell activation in the absence of class II major histocompatibility complex antigens. Inhibition by anti-L3T4 antibodies is a function both of epitope density and mode of presentation of anti-receptor antibody.
    Owens T; Fazekas de St Groth B
    J Immunol; 1987 Apr; 138(8):2402-9. PubMed ID: 2435798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of major histocompatibility complex class I-restricted hapten recognition by mutation of the V-J joining of T cell receptor alpha chains.
    von Bonin A; Plaga S; Ruh H; Hebbelmann S; Pflugfelder U; Martin S; Weltzien HU
    Eur J Immunol; 1996 Jan; 26(1):179-86. PubMed ID: 8566064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-positive T cell receptor(high) thymocytes are resistant to peptide/major histocompatibility complex ligand-induced negative selection.
    Ghendler Y; Hussey RE; Witte T; Mizoguchi E; Clayton LK; Bhan AK; Koyasu S; Chang HC; Reinherz EL
    Eur J Immunol; 1997 Sep; 27(9):2279-89. PubMed ID: 9341770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of radiation leukemia viruses to a thymic lymphoma involves some class I molecules on the T cell as well as the T cell receptor complex.
    O'Neill HC
    J Mol Cell Immunol; 1989; 4(4):213-23. PubMed ID: 2558669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structures of murine MHC Class I H-2 D(b) and K(b) molecules in complex with CTL epitopes from influenza A virus: implications for TCR repertoire selection and immunodominance.
    Meijers R; Lai CC; Yang Y; Liu JH; Zhong W; Wang JH; Reinherz EL
    J Mol Biol; 2005 Feb; 345(5):1099-110. PubMed ID: 15644207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide variants reveal how antibodies recognize major histocompatibility complex class I.
    Hogquist KA; Grandea AG; Bevan MJ
    Eur J Immunol; 1993 Nov; 23(11):3028-36. PubMed ID: 8223880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral escape at the molecular level explained by quantitative T-cell receptor/peptide/MHC interactions and the crystal structure of a peptide/MHC complex.
    Tissot AC; Ciatto C; Mittl PR; Grütter MG; Plückthun A
    J Mol Biol; 2000 Sep; 302(4):873-85. PubMed ID: 10993729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-restricted recognition of viral antigens in HLA transgenic mice.
    Kievits F; Ivanyi P; Krimpenfort P; Berns A; Ploegh HL
    Nature; 1987 Oct 1-7; 329(6138):447-9. PubMed ID: 2821399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in TCR-MHC contacts subsequent to cross-recognition of class I MHC and singly substituted peptide variants.
    Ono T; DiLorenzo TP; Wang F; Kalergis AM; Nathenson SG
    J Immunol; 1998 Nov; 161(10):5454-63. PubMed ID: 9820521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major histocompatibility complex and T cell receptor interaction of the P91A tum- peptide.
    McCormick D; Stauss HJ; Thorpe C; Travers P; Dyson PJ
    Eur J Immunol; 1996 Dec; 26(12):2895-902. PubMed ID: 8977283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I molecule.
    Tynan FE; Reid HH; Kjer-Nielsen L; Miles JJ; Wilce MC; Kostenko L; Borg NA; Williamson NA; Beddoe T; Purcell AW; Burrows SR; McCluskey J; Rossjohn J
    Nat Immunol; 2007 Mar; 8(3):268-76. PubMed ID: 17259989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.